Fig. 2From: Clinical characteristics, management, and 5-year survival compared between no standard modifiable risk factor (SMuRFless) and ≥ 1 SMuRF ACS cases: an analysis of 15,051 cases from PakistanKaplan Meier curves of survival probability over 60 months for SMuRFless and ≥ 1 SMuRF groupsBack to article page